Diabetes-related quality of life in six European countries measured with the DOQ-30

References

• Booth AO, Lowis C, Hunter SJ, et al. Development and evaluation of a computer-based, self-management tool for people recently diagnosed with type 2 diabetes. J Diabetes Res. 2016;2016:3192673.
   PubMed Web of Science ®Google Scholar
• Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–737.
   PubMed Web of Science ®Google Scholar
• Danna SM, Graham E, Burns RJ, et al. Association between depressive symptoms and cognitive function in persons with diabetes mellitus: a systematic review. PLOS One. 2016;11(8):e0160809.
   PubMed Web of Science ®Google Scholar
• van Vugt M, de Wit M, Bader S, et al. Does low well-being modify the effects of PRISMA (Dutch DESMOND), a structured self-management-education program for people with type 2 diabetes? Prim Care Diabetes. 2016;10(2):103–110.
   PubMed Web of Science ®Google Scholar
• Vermeire E, Hearnshaw H, Rätsep A, et al. Obstacles to adherence in living with type-2 diabetes: an international qualitative study using meta-ethnography (EUROBSTACLE). Prim Care Diabetes. 2007;1(1):25–33.
   PubMedGoogle Scholar
• Hearnshaw H, Wright K, Dale J, et al. Development and validation of the diabetes obstacles questionnaire (DOQ) to assess obstacles in living with type 2 diabetes. Diabetic Med. 2007;24(8):878–882.
   PubMed Web of Science ®Google Scholar
• Vandekerckhove M, Vermeire E, Weeren A, et al. Validation of the Diabetes Obstacles Questionnaire (DOQ) to assess obstacles in living with type 2 diabetes in a Belgian population. Prim Care Diabetes. 2009;3(1):43–47.
   PubMed Web of Science ®Google Scholar
• Pilv L, Rätsep A, Oona M, et al. Prevalent obstacles and predictors for people living with type 2 diabetes. Int J Family Med. 2012;2012:842912.
   PubMedGoogle Scholar
• Pilv L, Vermeire E, Rätsep A, et al. Development and validation of the short version of the diabetes obstacles questionnaire (DOQ-30) in six European countries. Eur J Gen Pract. 2016;22(1):16–22.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016.
   Google Scholar
• Funnell MM, Bootle S, Stuckey HL. The diabetes attitudes, wishes and needs second study. Clin Diabetes. 2015;33(1):32–36.
   PubMedGoogle Scholar
• Snoek FJ, Kersch NYA, Eldrup E, et al. Monitoring of Individual Needs in Diabetes (MIND)-2: follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study. Diabetes Care. 2012;35(11):2128–2132.
   PubMed Web of Science ®Google Scholar
• Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Statist Med. 1998;17(8):857–872.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Promoting health and reducing disparities in populations. Diabetes Care. 2017;40(Suppl 1):S6–S10.
   PubMedGoogle Scholar
• Bhagavathula AS, Gebreyohannes EA, Abegaz TM, et al. Perceived obstacles faced by diabetes patients attending University of Gondar Hospital, Northwest Ethiopia. Front Public Health. 2018;6:81.
   PubMed Web of Science ®Google Scholar
• Rossi MC, Lucisano G, Pintaudi B, et al. The complex interplay between clinical and person-centered diabetes outcomes in the two genders. Health Qual Life Outcomes. 2017;15(1):41.
   PubMed Web of Science ®Google Scholar
• Donald M, Dower J, Coll JR, et al. Mental health issues decrease diabetes-specific quality of life independent of glycaemic control and complications: findings from Australia's living with diabetes cohort study. Health Qual Life Outcomes. 2013;11:170.
   PubMed Web of Science ®Google Scholar
• Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med. 2002;19(4):279–284.
   PubMed Web of Science ®Google Scholar
• Pagkalos E, Thanopoulou A, Sampanis C, et al. The real-life effectiveness and care patterns of type 2 diabetes management in Greece. Exp Clin Endocrinol Diabetes. 2018;126(01):53–60.
   PubMed Web of Science ®Google Scholar
• Peyrot M, Barnett AH, Meneghini LF, et al. Factors associated with injection omission/non-adherence in the global attitudes of patients and physicians in insulin therapy study. Diabetes Obes Metab. 2012;14(12):1081–1087.
   PubMed Web of Science ®Google Scholar
• Chung JO, Cho DH, Chung DJ, et al. Assessment of factors associated with the quality of life in Korean type 2 diabetic patients. Intern Med. 2013;52(2):179–185.
   PubMed Web of Science ®Google Scholar
• Jones A, Olsen MZ, Perrild HJD, et al. The psychological impact of living with diabetes: Descriptive findings from the DAWN2 study in Denmark. Prim Care Diabetes. 2016;10(1):83–86.
   PubMed Web of Science ®Google Scholar
• Odawara M, Ishii H, Tajima N, et al. Impact of patient attitudes and beliefs to insulin therapy upon initiation, and their attitudinal changes after initiation: the DAWN Japan study. Curr Med Res Opin. 2016;32(4):681–686.
   PubMed Web of Science ®Google Scholar
• Kuznetsov L, Griffin SJ, Davies MJ, et al. Diabetes-specific quality of life but not health status is independently associated with glycaemic control among patients with type 2 diabetes: a cross-sectional analysis of the ADDITION-Europe trial cohort. Diabetes Res Clin Pract. 2014;104(2):281–287.
   PubMed Web of Science ®Google Scholar
• Depablos-Velasco P, Salguero-Chaves E, Mata-Poyo J, et al. Quality of life and satisfaction with treatment in subjects with type 2 diabetes: results in Spain of the PANORAMA study. Endocrinol Nutr. 2014;61(1):18–26.
   PubMed Web of Science ®Google Scholar
• Sundaram M, Kavookjian J, Patrick JH, et al. Quality of life, health status and clinical outcomes in type 2 diabetes patients. Qual Life Res. 2007;16(2):165–177.
   PubMed Web of Science ®Google Scholar
• Fisher L, Skaff MM, Mullan JT, et al. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med. 2008;25(9):1096–1101.
   PubMed Web of Science ®Google Scholar
• Nouwen A, Winkley K, Twisk J, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–2486.
   PubMed Web of Science ®Google Scholar
• Vallis M, Burns KK, Hollahan D, et al. Diabetes Attitudes, Wishes and Needs second study (DAWN2): understanding diabetes-related psychosocial outcomes for Canadians with diabetes. Can J Diabetes. 2016;40(3):234–241.
   PubMed Web of Science ®Google Scholar
• Hansen UM, Jones A, Zander M, et al. Denmark's comparative position regarding health status, healthcare provision, self-management and social support: Diabetes Attitudes, Wishes and Needs second study (DAWN2). Scand J Public Health. 2015;43(2):111–116.
   PubMed Web of Science ®Google Scholar
• Reach G, Consoli SM, Halimi S, et al. The multinational second Diabetes, Attitudes, Wishes and Needs study: results of the French survey. Patient Prefer Adherence. 2015;9:289–297.
   PubMed Web of Science ®Google Scholar
• Tarkun İ, Dumanli Özgöksu S. Attitudes, wishes, and needs of diabetes patients and their relatives: Turkish data from the DAWN2 study. Turk J Med Sci. 2017;47(2):447–454.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ting RZ, Yang W, et al. Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence. J Diabetes. 2015;7(6):800–808.
   PubMed Web of Science ®Google Scholar
• Nicolucci A, Kovacs Burns K, Holt RIG, et al. Correlates of psychological outcomes in people with diabetes: results from the second Diabetes Attitudes, Wishes and Needs (DAWN2(™)) study. Diabet Med. 2016;33(9):1194–1203.
   PubMed Web of Science ®Google Scholar